Vanda Pharmaceuticals's average Accounts Receivable for the
three
months ended in Dec. 2023 was $31.7 Mil. Vanda Pharmaceuticals's Revenue for the
three
months ended in Dec. 2023 was $45.3 Mil.
Hence, Vanda Pharmaceuticals's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 63.92.
The historical rank and industry rank for Vanda Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:
VNDA'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.69 Med: 43.14 Max: 64.11
Current: 58.76
During the past 13 years, Vanda Pharmaceuticals's highest Days Sales Outstanding was 64.11. The lowest was 20.69. And the median was 43.14.
VNDA's Days Sales Outstanding is ranked better than 60.59% of 888
companies
in the Biotechnology industry
Industry Median: 72.335
vs VNDA: 58.76
Vanda Pharmaceuticals's Days Sales Outstanding
increased
from Dec. 2022 (44.48) to Dec. 2023 (63.92).
Vanda Pharmaceuticals Days Sales Outstanding Historical Data
The historical data trend for Vanda Pharmaceuticals's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Vanda Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vanda Pharmaceuticals Days Sales Outstanding Distribution
For the Biotechnology industry and Healthcare sector, Vanda Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Vanda Pharmaceuticals's Days Sales Outstanding falls into.
Vanda Pharmaceuticals Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vanda Pharmaceuticals (NAS:VNDA) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Vanda Pharmaceuticals Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Vanda Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Vanda Pharmaceuticals (Vanda Pharmaceuticals) Business Description
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include VHX-896 and ASO Molecules. The majority of revenue is derived from HETLIOZ product sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VNDA has been successfully added to your 